Quantcast

Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Research paper by Coutre, S, Tedeschi, A, Robak, T, Barr, P. M, Owen, C, Bairey, O, Burger, J, Zhou, et al.

Indexed on: 10 Jun '18Published on: 04 Jun '18Published in: Haematologica



Abstract

Authors: Coutre, S ; Tedeschi ; A ; Robak ; T ; Barr ; P. M ; Owen ; C ; Bairey ; O ; Burger ; J ; Zhou ; C ; Styles ; L ; James ; D. F ; Kipps ; T. J. Article URL: http://www.haematologica.org/cgi/reprint/103/6/e249?rss=1 Citation: Vol 103 No. 6 (2018) pp e249 e251 Publication Date: 2018-06-03T23:55:04-07:00 Journal: Haematologica - the Hematology journal